Persistent Sydenham’s chorea is not associated with sustained lymphocyte dysfunction

The mechanisms involved in the symptoms of Sydenham's chorea (SC) remain obscure. Taking into account the autoreactive antibody-mediated hypothesis of SC pathogenesis, the persistence of chorea may be associated with increased levels of B1 lymphocytes and other lymphocyte subsets. We evaluated lymphocyte subsets, including B1 and T cells, in patients with remitted (RSC) and persistent (PSC) SC by flow cytometry. Our results showed neither difference in the frequency of T and B lymphocytes subpopulations nor in their activation and functional states. These findings undermine the view of PSC as a sustained cytotoxic cellular-mediated condition. Alternative mechanisms may explain the pathogenesis of PSC.

[1]  F. Cardoso,et al.  Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: A pilot study to investigate the potential of SC antibodies to increase dopaminergic activity , 2012, Neuroscience Letters.

[2]  R. Dale,et al.  Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome , 2011, Neurology.

[3]  A. Teixeira,et al.  Monocyte dysfunction in Sydenham's chorea patients. , 2010, Human immunology.

[4]  R. Goertsches,et al.  Immunoglobulins—Basic considerations , 2006, Journal of Neurology.

[5]  L. Chess,et al.  Regulation of immune responses by T cells. , 2006, The New England journal of medicine.

[6]  A. Teixeira,et al.  Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy. , 2005, Parkinsonism & related disorders.

[7]  A. Teixeira,et al.  Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement‐independent mechanism , 2005, Movement disorders : official journal of the Movement Disorder Society.

[8]  A. Teixeira,et al.  Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea , 2005, Neurology.

[9]  F. Cardoso,et al.  UFMG Sydenham's chorea rating scale (USCRS): Reliability and consistency , 2005, Movement disorders : official journal of the Movement Disorder Society.

[10]  F. Cardoso.  Chorea: non-genetic causes , 2004, Current opinion in neurology.

[11]  M. Teixeira,et al.  Increased serum concentrations of monokine induced by interferon-γ/CXCL9 and interferon-γ-inducible protein 10/CXCL-10 in Sydenham's chorea patients , 2004, Journal of Neuroimmunology.

[12]  M. Teixeira,et al.  Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham's chorea patients. , 2004, Journal of neuroimmunology.

[13]  S. Swedo,et al.  Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea , 2003, Nature Medicine.

[14]  H. Lederman,et al.  Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea , 2003, Neuroradiology.

[15]  A. Lees,et al.  CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome? , 2003, Journal of Neuroimmunology.

[16]  F. Cardoso,et al.  Persistent Sydenham's chorea , 1999, Movement disorders : official journal of the Movement Disorder Society.

[17]  F. Cardoso,et al.  Chorea in fifty consecutive patients with rheumatic fever , 1997, Movement disorders : official journal of the Movement Disorder Society.

[18]  A. Bisno,et al.  Guidelines for the Diagnosis of Rheumatic Fever: Jones Criteria, Updated 1992 Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, American Heart Association , 1993 .

[19]  A. Bisno,et al.  Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. , 1992, JAMA.